Flying in the age of coronavirus comes packed with uncertainty about the health status of fellow travelers. Now, Florida's Tampa International Airport is running a pilot program that offers on-the-spot COVID-19 tests for travelers.
With more than 120 people participating in the optional testing per day, Joe Lopano, Tampa International Airport CEO, said the program is showing promising results.
"We've had some customers who have tested positive and Baycare, the healthcare professionals, have a discussion with that passenger and tell them that they should not continue on their way and passengers have accepted it," Lopano told Cheddar.
The airport offers two tests, the $125 PCR nasal swab, which usually takes 3 to 4 days to yield results, and the $50 rapid Antigen test. The cost of both tests, Lopano said, can be covered by insurance companies if travelers provide a receipt from the airport.
Testing at the airport, according to Lopano, will not have much impact on overall travel time. In fact, those not checking a bag only need to account for an additional 30 minutes as a cushion, he added.
"It's immediate testing. Sometimes you have to wait in a short line. You'll get your results in 15 minutes, so it really is not a very time-consuming function and it's very convenient," Lopano said.
While other airports have implemented testing for specific destinations, Lopano said Tampa is the first to offer widespread testing for passengers on all flights arriving and departing. The pilot program is likely to continue running through the holiday season as the number of participants and customer satisfaction is assessed.
For Lopano, offering a testing site at the airport is not only maintaining passenger safety but can also help revitalize a struggling travel industry that is fighting to get customers off the ground.
"It's a high priority because we need to do whatever we can to create confidence in the travel experience and now that widespread testing is available, the technology is available, what better way to do that than right at the airport," he said.
Although still early in development, blockchain technology, Web3, also known as Web 3.0 has been getting a lot of attention from some top tech names lately. Web3 is based on blockchain technology, which powers NFT’s and cryptocurrencies such as bitcoin. With Web3, users would ideally control their own data, rather than have it be controlled by a few large companies. But, Tesla CEO Elon musk isn't buying into Web3 just yet, tweeting over the weekend that the decentralized iteration of the internet seems more like a marketing "buzzword" right now than reality. Twitter co-founder Jack Dorsey also chiming in to the conversation, expressing doubt over whether or not Web3 would actually be decentralized if ownership still belonged to venture capital firms. Parker McCurley, co-founder & CEO of Decent Labs explains the significance of Web3 catching the eye of the tech giants, and what Web3 could mean for the future of the internet.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
On December 20th, the TSA reported that for the fourth day in a row, it had screened more than 2 million people through its airports as the Omicron variant continues to rage and spread rapidly throughout the country. The CDC now reporting that roughly 73% of all covid cases are caused by the Omicron variant ahead of President Biden’s remarks aimed towards curbing the virus and helping hospitals battle rises in hospitalizations. Dr. Nasia Safdar breaks down the latest on traveling during the pandemic.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Stocks closed lower Monday as investors continued to price in COVID-19 omicron variant fears. Reopening stocks like airlines, financial companies, restaurants and hotels, and more, dragged on the major indexes as businesses and events took a pause over the weekend amid rising case numbers in metropolitan areas. This comes a week after the Federal Reserve announced it plans to speed up its asset tapering timeline in January and institute three rate hikes next year. Is that plan aging well? Robert Conzo, CEO of The Wealth Alliance, joins Cheddar News' Closing Bell to discuss market movement, how stocks could close out the year, what the Fed could do in 2022, and more.
After a vote in one Buffalo, New York-area Starbucks created the first workers union in the coffee chain's history, the company has announced that it is ready to negotiate in good faith with the new bargaining unit. But a tense process where labor organizers leveled accusations of anti-union activity at the coffee giant may make that difficult. Cortlin Harrison, a barista at the unionized store, spoke to Cheddar about making a deal. "We can move past all the dirty tricks, the union-busting, the captive audience meetings," he said. "I'm ready to go to the table, and my fellow baristas are ready to go to the table, and just move forward."
